A Phase 2 Multi-center, Double-blinded, Placebo-controlled Study to Evaluate the Safety and Efficacy of VX809 Alone and In Combination With VX 770.
|Effective start/end date||11/4/10 → 9/11/15|
- VERTEX PHARMACEUTICALS INCORPORATED
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.